http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12677937

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 1519
issn 1557-3265
1078-0432
issueIdentifier 5
pageRange 1509-1519
publicationName Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage 1509
bibliographicCitation Wainberg ZA, Anghel A, Desai AJ, Ayala R, Luo T, Safran B, Fejzo MS, Hecht JR, Slamon DJ, Finn RS. Lapatinib, a dual EGFR and HER2 kinase inhibitor, selectively inhibits HER2-amplified human gastric cancer cells and is synergistic with trastuzumab in vitro and in vivo. Clin Cancer Res. 2010 Mar 01;16(5):1509–19. doi: 10.1158/1078-0432.ccr-09-1112. PMID: 20179222.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21aa0463e04af7211918a220216a78f9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b1b2c1c4d18cc827c6ee9886e6f9e1c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9dd6ccbd251e1ddb4effb9fbcb6f76ac
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c3f0a9b19b0495e7def6d41a1ac0617
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b60c1d8dd510c6f4aee2955decac734
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd40df330b0f1bfb10bf072cd14288a8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0bad332bc0d89721bdb053429b2efda
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_431e8e1f32ad8a8ac53adcf17c3c711c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c50c0a0a6406afe69da0c7910de2405
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc4c82ff4368e83990a82e6cea5f0e14
date 2010-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1158/1078-0432.ccr-09-1112
https://pubmed.ncbi.nlm.nih.gov/20179222
isPartOf https://portal.issn.org/resource/ISSN/1557-3265
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794
https://portal.issn.org/resource/ISSN/1078-0432
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Lapatinib, a Dual EGFR and HER2 Kinase Inhibitor, Selectively Inhibits HER2-Amplified Human Gastric Cancer Cells and is Synergistic with Trastuzumab In vitro and In vivo
discusses http://id.nlm.nih.gov/mesh/M0291428
http://id.nlm.nih.gov/mesh/M0028048
http://id.nlm.nih.gov/mesh/M0001357
http://id.nlm.nih.gov/mesh/M0556300
http://id.nlm.nih.gov/mesh/M0018336
http://id.nlm.nih.gov/mesh/M0493669
http://id.nlm.nih.gov/mesh/M0593322
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0473129
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D011799Q000494
http://id.nlm.nih.gov/mesh/D018719Q000096
http://id.nlm.nih.gov/mesh/D066246Q000096
http://id.nlm.nih.gov/mesh/D000970Q000494
http://id.nlm.nih.gov/mesh/D013274Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D000911Q000494
http://id.nlm.nih.gov/mesh/D017209Q000187
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000068878
http://id.nlm.nih.gov/mesh/D008819
http://id.nlm.nih.gov/mesh/D017404
http://id.nlm.nih.gov/mesh/D066246Q000235
http://id.nlm.nih.gov/mesh/D023041
http://id.nlm.nih.gov/mesh/D004357
http://id.nlm.nih.gov/mesh/D047468
http://id.nlm.nih.gov/mesh/D000069347
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D013274Q000235
http://id.nlm.nih.gov/mesh/D061067
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D049109Q000187
http://id.nlm.nih.gov/mesh/D015398Q000187
http://id.nlm.nih.gov/mesh/D018719Q000235
http://id.nlm.nih.gov/mesh/D000077341
http://id.nlm.nih.gov/mesh/D015153
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5957
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7812
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9305
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID208908

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127494626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127377427

Total number of triples: 77.